Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study

被引:109
作者
Bash, Lori D. [1 ,2 ]
Erlinger, Thomas P. [3 ]
Coresh, Josef [2 ,4 ,5 ]
Marsh-Manzi, Jane
Folsom, Aaron R. [6 ]
Astor, Brad C. [2 ,4 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21201 USA
[3] Seton Hosp, Austin, TX USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21201 USA
[6] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Inflammation; hemostasis; kidney; chronic kidney disease; Atherosclerosis Risk in Communities (ARIC); C-REACTIVE PROTEIN; HYPERTENSIVE PATIENTS; ADVANCED GLYCATION; NATIONAL-HEALTH; RENAL-DISEASE; ASSOCIATION; MARKERS; HEART; NEPHROPATHY; PROGRESSION;
D O I
10.1053/j.ajkd.2008.10.044
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Background: Inflammation and hemostasis may increase the risk of kidney function decline; however, data from prospective studies are sparse. Study Design: The Atherosclerosis Risk in Communities (ARIC) Study, a prospective observational cohort. Setting & Participants: We used data from 14,854 middle-aged adults from 4 different US communities. Predictor: Markers of inflammation and hemostasis were examined. Outcomes & Measurements: The risk of kidney function decrease associated with these markers was studied. Glomerular filtration rate (GFR) was calculated from serum creatinine levels using the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation. Chronic kidney disease (CKD) was defined as: (1) a decrease in estimated GFR to less than 60 mL/min/1.73 m(2) from greater than 60 mL/min/1.73 m(2) at baseline, or (2) a hospitalization discharge or death coded for CKD. Serum creatinine was measured at baseline and the 3- and 9-year follow-up visits. Hazard ratios (HRs) of CKD associated with increased levels of inflammatory and hemostatic variables were estimated by using multivariate Cox proportional hazards regression. Results: 1,787 Gases of CKD developed between 1987 and 2004. After adjusting for demographics, smoking, blood pressure, diabetes, lipid levels, prior myocardial infarction, antihypertensive use, alcohol use, year of marker measurement, and baseline renal function using estimated GFR, the risk of incident CKD increased with increasing quartiles of white blood cell count (HR quartile 4 versus quartile 1, 1.30; 95% confidence interval [CI], 1.12 to 1.50; Ptrend = 0.001), fibrinogen (HR, 1.25; 95% CI, 1.09 to 1.44; P< 0.001), von Willebrand factor (HR, 1.46; 95% CI, 1.26 to 1.68; P < 0.001), and factor VIIIc (HR, 1.39; 95% CI, 1.20 to 1.60; P < 0.001). A strong inverse association was found between serum albumin level and risk of CKD (HR, 0.63; 95% CI, 0.55 to 0.72; P< 0.001). No independent association was found with factor VIIc level. Limitations: Although we lacked a direct measure of kidney function, associations were robust to case definitions. Conclusions: Markers of inflammation and hemostasis are associated with greater risk of kidney function decrease. Findings suggest that inflammation and hemostasis are antecedent pathways for CKD. Am J Kidney Dis 53:596-605. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:596 / 605
页数:10
相关论文
共 34 条
[1]
[Anonymous], OP MAN 9 HEM DET VER
[2]
Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population [J].
Bleyer, AJ ;
Shemanski, LR ;
Burke, GL ;
Hansen, KJ ;
Appel, RG .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2072-2079
[3]
APPROXIMATE QUASI-LIKELIHOOD ESTIMATION IN MODELS WITH SURROGATE PREDICTORS [J].
CARROLL, RJ ;
STEFANSKI, LA .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1990, 85 (411) :652-663
[4]
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance [J].
Catena, C ;
Zingaro, L ;
Casaccio, D ;
Sechi, LA .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (07) :556-561
[5]
Chambless L E, 1992, Ann Epidemiol, V2, P723
[6]
Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States - Perface [J].
Collins, AJ ;
Kasiske, B ;
Herzog, C ;
Chavers, B ;
Foley, R ;
Gilbertson, D ;
Grimm, R ;
Liu, JN ;
Louis, T ;
Manning, W ;
Matas, A ;
McBean, M ;
Murray, A ;
St Peter, W ;
Xue, J ;
Fan, Q ;
Guo, HF ;
Li, SL ;
Li, SY ;
Roberts, T ;
Snyder, J ;
Solid, C ;
Wang, CC ;
Weinhandl, E ;
Arko, C ;
Chen, SC ;
Dalleska, F ;
Daniels, F ;
Dunning, S ;
Ebben, J ;
Frazier, E ;
Johnson, R ;
Sheets, D ;
Forrest, B ;
Berrini, D ;
Constantini, E ;
Everson, S ;
Frederick, P ;
Eggers, P ;
Agodoa, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :V-+
[7]
Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease [J].
Cooper, ME .
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (12) :31S-38S
[8]
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[9]
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[10]
ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496